Skip to Main Content

Paper Details

Modulation of the Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination by Nonsteroidal Anti-Inflammatory Drugs.
J Pharmacol Exp Ther
1
2023
CoV, Coronavirus 2, IgG antibody, RBD, SARS, SARS-CoV-2, Severe Acute Respiratory Syndrome, coronavirus 2, receptor binding domain, severe acute respiratory syndrome, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
Carsten SkarkeInstitute for Translational Medicine and Therapeutics (C.S., Institute for Immunology (D.M., University of Pennsylvania Perelman School of Medicine
Ronan LordanInstitute for Translational Medicine and Therapeutics (C.S., Institute for Immunology (D.M., University of Pennsylvania Perelman School of Medicine
Amruta NaikInstitute for Translational Medicine and Therapeutics (C.S., Institute for Immunology (D.M., University of Pennsylvania Perelman School of Medicine
Gregory R GrantInstitute for Translational Medicine and Therapeutics (C.S., Institute for Immunology (D.M., University of Pennsylvania Perelman School of Medicine
Nicholas F LahensInstitute for Translational Medicine and Therapeutics (C.S., Institute for Immunology (D.M., University of Pennsylvania Perelman School of Medicine
Aalim M WeljieInstitute for Translational Medicine and Therapeutics (C.S., Institute for Immunology (D.M., University of Pennsylvania Perelman School of Medicine
Garret A FitzGeraldInstitute for Translational Medicine and Therapeutics (C.S., Institute for Immunology (D.M., University of Pennsylvania Perelman School of Medicine
Garret A FitzGeraldInstitute for Translational Medicine and Therapeutics (C.S., Institute for Immunology (D.M., University of Pennsylvania Perelman School of Medicine
  • 1 - 8

Datasets

Release 1.2